203 related articles for article (PubMed ID: 25337250)
1. Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.
Lu X; Xu Q; Bu X; Ma X; Zhang F; Deng Q; Zhang Y; Ding J
Int J Clin Exp Pathol; 2014; 7(9):6048-55. PubMed ID: 25337250
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
3. Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Kataki K; Borthakur P; Kumari N; Deka M; Kataki AC; Medhi S
J Med Virol; 2017 Jun; 89(6):1008-1014. PubMed ID: 27769109
[TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
5. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
6. Correlation of circulating TLR2/4 expression with CD3+/4+/8+ T cells and Treg cells in HBV-related liver cirrhosis.
Lian JQ; Wang XQ; Zhang Y; Huang CX; Bai XF
Viral Immunol; 2009 Oct; 22(5):301-8. PubMed ID: 19811087
[TBL] [Abstract][Full Text] [Related]
7. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.
Du WJ; Zhen JH; Zeng ZQ; Zheng ZM; Xu Y; Qin LY; Chen SJ
Diagn Pathol; 2013 Feb; 8():40. PubMed ID: 23448394
[TBL] [Abstract][Full Text] [Related]
9. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
Kim GA; Han S; Choi GH; Choi J; Lim YS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
[TBL] [Abstract][Full Text] [Related]
10. [The influence of hepatitis B e antigen on the expression of toll-like receptor 2 on peripheral monocytes].
Han YP; Li J; Wan YF; Kong LH; Cai J; Dong L; Liu Y; Chen N; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2008 Oct; 16(10):739-42. PubMed ID: 18983769
[TBL] [Abstract][Full Text] [Related]
11. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
[TBL] [Abstract][Full Text] [Related]
12. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection.
Gu S; Fu X; Ye G; Chen C; Li X; Zhong S; Tang L; Chen H; Jiang D; Hou J; Li Y
Front Immunol; 2021; 12():649197. PubMed ID: 34234772
[TBL] [Abstract][Full Text] [Related]
13. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
14. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
15. Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
Bagheri V; Askari A; Arababadi MK; Kennedy D
Hum Immunol; 2014 Jun; 75(6):549-54. PubMed ID: 24530748
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
Marusawa H; Osaki Y; Kimura T; Ito K; Yamashita Y; Eguchi T; Kudo M; Yamamoto Y; Kojima H; Seno H; Moriyasu F; Chiba T
Gut; 1999 Aug; 45(2):284-8. PubMed ID: 10403743
[TBL] [Abstract][Full Text] [Related]
17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
18. Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.
Zhao XL; Yang JR; Lin SZ; Ma H; Guo F; Yang RF; Zhang HH; Han JC; Wei L; Pan XB
Gut; 2016 Mar; 65(3):502-11. PubMed ID: 26045139
[TBL] [Abstract][Full Text] [Related]
19. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
20. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.
Tada T; Kumada T; Toyoda H; Ohisa M; Akita T; Tanaka J
J Gastroenterol; 2018 Nov; 53(11):1196-1205. PubMed ID: 29675604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]